Asiana vs Jazz Pharmaceuticals Which Is More Favorable?

Asiana Airlines and Jazz Pharmaceuticals are two companies operating in very different industries – the former in the airline industry and the latter in the pharmaceutical industry. Asiana's stock performance may be influenced by factors such as fuel prices, demand for air travel, and competition, while Jazz Pharmaceuticals' stock may be influenced by drug approvals, clinical trial results, and market demand for its products. Both stocks offer potential for growth, but investors should carefully consider the unique factors affecting each company's performance.

Asiana or Jazz Pharmaceuticals?

When comparing Asiana and Jazz Pharmaceuticals, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between Asiana and Jazz Pharmaceuticals.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. Asiana has a dividend yield of 8.57%, while Jazz Pharmaceuticals has a dividend yield of -%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. Asiana reports a 5-year dividend growth of 13.94% year and a payout ratio of 99.80%. On the other hand, Jazz Pharmaceuticals reports a 5-year dividend growth of 0.00% year and a payout ratio of 24.24%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with Asiana P/E ratio at 8.35 and Jazz Pharmaceuticals's P/E ratio at 16.31. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. Asiana P/B ratio is 1.06 while Jazz Pharmaceuticals's P/B ratio is 1.81.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, Asiana has seen a 5-year revenue growth of -0.01%, while Jazz Pharmaceuticals's is 0.92%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with Asiana's ROE at 12.72% and Jazz Pharmaceuticals's ROE at 12.06%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are ฿8.35 for Asiana and $121.22 for Jazz Pharmaceuticals. Over the past year, Asiana's prices ranged from ฿6.35 to ฿11.20, with a yearly change of 76.38%. Jazz Pharmaceuticals's prices fluctuated between $99.06 and $134.17, with a yearly change of 35.44%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.